Patent · US Active

Glycoconjugates and their use as potential vaccines against infection by Shigella flexneri

US9446109B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE) · FR

Inventors

Armelle Phalipon · Paris, FR
Farida Nato · Antony, FR
Laurence Mulard · Le Kremlin-Bicêtre, FR
Philippe Sansonetti · Paris, FR
Francoise Baleux · Paris, FR
Frédéric Belot · Grenoble, FR
Cyrille Grandjean · Châteauroux, FR

Key dates

Filing date	Dec 14, 2011
Grant date	Sep 20, 2016
Priority date	—
Expiry date	Apr 20, 2035

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A conjugate molecule comprising an oligo- or polysaccharide covalently bound to a carrier and its use as potential vaccine against infection by S. Flexneri.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.